Tender Summary

Molecular Screening Services

Buying Organisation

NHS Blood and Transplant

Contract Value

£9,500,000

Tender Description

This Contract notice is a call for competition and is separate to any tender opportunity. Its purpose is to inform the market of a tender opportunity. NHS Blood and Transplant are looking for a Managed Service provider to provide a fully integrated high throughput testing solution for an automated Nucleic Acid Amplification Testing (NAT) system which can detect HBV DNA, HIV-1 RNA, HIV-2 RNA, HCV RNA, HEV RNA in EDTA plasma from blood and non-blood (e.g. stem cell, tissue) donors including from deceased (non-heart beating) donors. The solution must have the relevant CE/UKCA marking to support this ability.
Participation is subject to the Supplier currently participating in the NHSBT KEG process, or confirmation that their testing solution has previously been KEG approved to deliver Molecular Screening in partnership with NHSBT. All correspondence to: tennille.madigan@nhsbt.nhs.uk

Tender categories (products & services required)

Laboratory services (CPV 71900000)
Medical equipments, pharmaceuticals and personal care products (CPV 33000000)
Laboratory reagents (CPV 33696500)
Blood-testing reagents (CPV 33696200)
Automation system (CPV 48921000)
Diagnostic kits (CPV 33141625)
Diagnostic systems (CPV 33124110)
Medical consumables (CPV 33140000)
Diagnostics and radiodiagnostic devices and supplies (CPV 33124000)
Immuno-analysis devices (CPV 33127000)

Region

South West (UKK)

Buyer Information

NHS Blood and Transplant

  Further information on this tender from NHS Blood and Transplant when you create a FREE Account

Other tenders you might like

You have more tenders waiting!

View all of your tenders, see forthcoming opportunities, access data/reports.